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Dear Editor-in-Chief 
 
Despite the widespread use of chemical agents in 
the field of cardiovascular diseases, today, univer-
sal approach is towards natural remedies. Old 
medical schools are important sources of natural 
medicines and one of the most impressive ancient 
scientists is Avicenna (980-1037 AD). Avicenna 
not only devoted a chapter of Canon to heart dis-
eases and their treatment but also wrote a treatise 
on cardiac drugs. The name of this essay is "Al-
Resaleh fi Al-Adviyah Al-ghalbyah" which includes 
multiple simple cardiotonics such as Rose (Rosa 
damascena L.) and amla (Emblica officinalis Gaertn.) 
(1).  
Rose is a cardiotonic drug due to its fragrance and 
astringency power (1). Two cardiotonic products 
of rose are rose water and sugary "goleghand" (an 
electuary that is made of rose petals and sugar) (2). 
On the other hand, recent studies demonstrated 
that rose has inotropic effect (3), and recovers 
cardiovascular function (4). Amla is a cardiotonic 
drug because of being astringent and strengthen-
ing the cardiac mass. It has been shown that amla 
can improve contractile function and tissue anti-
oxidant status (5) and protect rat hearts from oxi-
dative stress (6). 
Avicenna's definition of cardiotonic is comparable 
in part to its modern definition, however, encom-
passes more details. According to Canon, astrin-
gency power ("ghabz"), being fragrant, and desic-
cation ("tajfif") or drying redundant moistures are 
the most important traditional mechanisms of ac-
tion of cardiotonics (2). 
Additionally, some drugs such as cinnamon, pista-
chio, and camphor have an inherent individual 
property, which is named as "theriaqiyat" (being 
antidote). The action of antidote drugs is related 
to reinforcement of the nature ("tabiat") (2). 
"Theriaqiyat" may be considered as an analogous 
to antioxidative property; because, the drugs with 
these two properties can eliminate the harmful 
effects of toxins. Moreover, astringency power 
may be matching to myocardial contractility in 
some simple drugs. However, research that is 
more extensive is needed to confirm these theo-
ries. 
We can rationalize the effectiveness of traditional 
cardiotonics in treatment of heart diseases by 
means of previously mentioned mechanisms. For 
example, a drug, which is astringent or desiccant, 
can be considered as a good remedy for cardiac 
diseases such as edema, dilated cardiomyopathy, 
and pericarditis, which originate from tissue laxity 
due to excess moisture. Moreover, cardiac diseases 
due to weak action of myocardium or valves can 
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be treated by use of astringent, mass toner, and 
aromatic natural drugs. Finally, some plants which 
are usually a part of our diet are cardiotonic and 
easily accessible. We can consume apple, amla jam, 
quince syrup, and rose water without any consid-
erable side effect. Moreover, smelling fine and 
compatible aromas such as rose essence and pre-
vention from unpleasant odors are effective in 
strengthening heart. 
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